Irreversible Pulpitis
Conditions
Keywords
Pulpotomy, Magnification, Clinical experience, Irreversible pulpitis
Brief summary
The goal of this interventional randomized clinical trial is to test the effect of magnification and clinical experience of the operator on the success rate of full pulpotomy in mature adult molar teeth. The main questions it aims to answer are: * Does the use of magnification raise the success rate of full pulpotomy of mature adult molars? * Does the clinical experience of the operator dentist raise the success rate of full pulpotomy of mature adult molars? Participants will be asked to do the following: * Receive the pulpotomy treatment of their target molar tooth. * Record the pain score in the pain assessment chart. * Attend the follow-up visits. They'll receive a full pulpotomy treatment of their target molar tooth. Researchers will evaluate the usage of magnification in performing the pulpotomy procedure of adult molar teeth by postgraduate or undergraduate operators in comparison to performing the same pulpotomy procedure without magnification to see if it raises the overall success rate of pulpotomy.
Interventions
The adult pulpotomy procedure of mature molars will be carried out with the use of magnification (dental loupes or microscope) in healthy patients. The procedure will be performed either by postgraduate or undergraduate operators.
Sponsors
Study design
Eligibility
Inclusion criteria
* Healthy patients diagnosed with acute irreversible pulpitis related to maxillary or mandibular permanent molar teeth without apical periodontitis.
Exclusion criteria
* Non-vital teeth. * Immature teeth. * Presence of swelling or sinus tract. * Teeth with mobility grade II or III. * Immunocompromised patients. * Non-restorable teeth. * Teeth with apical periodontitis seen in periapical radiograph. * Periodontally affected teeth. * Teeth with reversible pulpitis * Extensive non-stoppable bleeding more than 6 minutes * Teeth with partial necrosis
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Clinical and radiographic outcome | Immediately, 1, 3, 6 and 12 months. | The clinical outcome will be measured by the presence or absence of signs and symptoms. The radiographic outcome will be measured by using the PAI index which is a scale from 1 (best) to 5 (worst). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Postoperative pain | Immediately, 24, 48, 72 hours and 7 days | The postoperative pain will be measured by the modified Verbal Descriptor Scale which is a scale from 0 (best) to 10 (worst). |
Countries
Egypt